Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care

被引:1672
作者
De Hert, Marc [1 ]
Correll, Christoph U. [2 ]
Bobes, Julio [3 ]
Cetkovich-Bakmas, Marcelo [4 ,5 ]
Cohen, Dan [6 ]
Asai, Itsuo
Detraux, Johan [1 ]
Gautam, Shiv [7 ]
Moeller, Hans-Jurgen [8 ]
Ndetei, David M. [9 ,10 ]
Newcomer, John W. [11 ]
Uwakwe, Richard [12 ]
Leucht, Stefan [13 ]
机构
[1] Katholieke Univ Leuven, Univ Psychiat Ctr, B-3070 Kortenberg, Belgium
[2] Albert Einstein Coll Med, Bronx, NY 10467 USA
[3] Univ Oviedo CIBERSAM, Dept Psychiat Med, Oviedo, Spain
[4] Favaloro Univ Hosp, Dept Psychiat, Inst Cognit Neurol, Buenos Aires, DF, Argentina
[5] Favaloro Univ Hosp, Dept Psychiat, Inst Neurosci, Buenos Aires, DF, Argentina
[6] Univ Groningen, Dept Epidemiol, NL-9700 AB Groningen, Netherlands
[7] Coll Med, Ctr Psychiat, Jaipur, Rajasthan, India
[8] Univ Munich, Dept Psychiat, D-80539 Munich, Germany
[9] Univ Nairobi, Nairobi, Kenya
[10] Africa Mental Hlth Fdn, Nairobi, Kenya
[11] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA
[12] Nnamdi Azikiwe Univ, Fac Med, Nnewi, Nigeria
[13] Tech Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany
关键词
Physical illness; severe mental illness; bipolar disorder; depression; schizophrenia; psychotropic medication; health disparities; BONE-MINERAL DENSITY; HUMAN-IMMUNODEFICIENCY-VIRUS; INDUCED WEIGHT-GAIN; BODY-MASS INDEX; MAJOR DEPRESSIVE DISORDER; CORONARY-HEART-DISEASE; HIV-RISK BEHAVIOR; QUALITY-OF-LIFE; CATIE SCHIZOPHRENIA TRIAL; INTERNATIONAL-DIABETES-FEDERATION;
D O I
10.1002/j.2051-5545.2011.tb00014.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The lifespan of people with severe mental illness (SMI) is shorter compared to the general population. This excess mortality is mainly due to physical illness. We report prevalence rates of different physical illnesses as well as important individual lifestyle choices, side effects of psychotropic treatment and disparities in health care access, utilization and provision that contribute to these poor Physical health outcomes. We searched MEDLINE (1966 August 2010) combining the MeSH terms of schizophrenia, bipolar disorder and major depressive disorder with the different MeSH terms of general physical disease categories to select pertinent reviews' and additional relevant studies through cross-referencing to identify prevalence figures and factors. contributing to the excess morbidity and mortality rates. Nutritional and metabolic diseases, cardiovascular diseases, viral diseases, respiratory tract diseases, musculoskeletal diseases, sexual dysfunction, pregnancy complications, stomatognathic diseases, and possibly obesity-related cancers are, compared to the general population, more prevalent among people with SMI It seems that lifestyle as well as treatment specific factors account for much of the increased risk for most of these physical diseases. Moreover, there is sufficient evidence that people with SMI are less likely to receive standard levels of care for most, of these diseases. Lifestyle factors, relatively easy to measure, are barely considered for screening; baseline testing of numerous important physical parameters is insufficiently performed. Besides modifiable lifestyle factors and side effects of psychotropic medications, access to and quality of health care remains to be improved for individuals with SMI.
引用
收藏
页码:52 / 77
页数:26
相关论文
共 588 条
[61]   Reduced cancer incidence among patients with schizophrenia [J].
Barak, Y ;
Achiron, A ;
Mandel, M ;
Mirecki, I ;
Aizenberg, D .
CANCER, 2005, 104 (12) :2817-2821
[62]   Symptoms of depression, acute myocardial infarction, and total mortality in a community sample [J].
Barefoot, JC ;
Schroll, M .
CIRCULATION, 1996, 93 (11) :1976-1980
[63]   A UK audit of screening for the metabolic side effects of antipsychotics in community patients [J].
Barnes, Thomas R. E. ;
Paton, Carol ;
Cavanagh, Mary-Rose ;
Hancock, Elizabeth ;
Taylor, David M. .
SCHIZOPHRENIA BULLETIN, 2007, 33 (06) :1397-1403
[64]   Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia [J].
Barnett, A. H. ;
Mackin, P. ;
Chaudhury, I. ;
Farooqi, A. ;
Gadsby, R. ;
Heald, A. ;
Hill, J. ;
Millar, H. ;
Peveler, R. ;
Rees, A. ;
Singh, V. ;
Taylor, D. ;
Vora, J. ;
Jones, P. B. .
JOURNAL OF PSYCHOPHARMACOLOGY, 2007, 21 (04) :357-373
[65]   The prevalence of the metabolic syndrome in patients with schizoaffective disorder - bipolar subtype [J].
Basu, R ;
Brar, JS ;
Chengappa, KNR ;
John, V ;
Parepally, H ;
Gershon, S ;
Schlicht, P ;
Kupfer, DJ .
BIPOLAR DISORDERS, 2004, 6 (04) :314-318
[66]   Medical comorbidity in patients with schizophrenia and alcohol dependence [J].
Batki, Steven L. ;
Meszaros, Zsuzsa S. ;
Strutynski, Katherine ;
Dimmock, Jacqueline A. ;
Leontieva, Luba ;
Ploutz-Snyder, Robert ;
Canfield, Kelly ;
Drayer, Rebecca A. .
SCHIZOPHRENIA RESEARCH, 2009, 107 (2-3) :139-146
[67]   LITHIUM MAINTENANCE TREATMENT OF MANIC-MELANCHOLIC PATIENTS - ROLE IN DAILY ROUTINE [J].
BECH, P ;
VENDSBORG, PB ;
RAFAELSEN, OJ .
ACTA PSYCHIATRICA SCANDINAVICA, 1976, 53 (01) :70-81
[68]   Risperidone, but not olanzapine, decreases bone mineral densitv in female premenopausal schizophrenia patients [J].
Becker, D ;
Liver, O ;
Mester, R ;
Rapoport, M ;
Weizman, A ;
Weiss, M .
JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (07) :761-766
[69]   High bone turnover but normal bone mineral density in women suffering from schizophrenia [J].
Bergemann, N. ;
Parzer, P. ;
Mundt, C. ;
Auler, B. .
PSYCHOLOGICAL MEDICINE, 2008, 38 (08) :1195-1201
[70]   Management of sexual dysfunction due to antipsychotic drug therapy [J].
Berner, M. M. ;
Hagen, M. ;
Kriston, L. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01)